Proximal Humerus Cartilaginous Tumors: Navigating the Enchondroma-Chondrosarcoma Dilemma
Key Takeaway
Differentiating enchondroma from low-grade chondrosarcoma in the proximal humerus involves assessing progressive pain, clinical findings, and detailed imaging. Key diagnostic indicators on X-ray and CT include chondroid matrix calcifications and the depth of endosteal scalloping. Significant scalloping (e.g., 3-4mm) with persistent pain strongly suggests potential for low-grade chondrosarcoma.
A 48-year-old male presents with 6 months of increasing shoulder pain. He describes a dull ache, particularly with overhead activity, and reports night pain. There is no history of trauma or constitutional symptoms. You are provided with this initial radiograph of his left shoulder. What is your differential diagnosis and how would you proceed with your workup?
Candidate: The radiograph shows a radiolucent, possibly lobulated lesion in the proximal humerus with some internal calcifications. My main differentials would be an enchondroma or a low-grade chondrosarcoma. Since he has pain and night pain, I would order an MRI to look for soft tissue mass and endosteal scalloping, and perhaps a CT for cortical integrity.
Failing to emphasize the clinical significance of "pain" in a cartilaginous lesion. A weak candidate often treats this as an incidentaloma, ignoring the fact that pain in this setting is a red flag for malignancy. They also fail to mention the need to exclude secondary causes (like rotator cuff pathology) that could be responsible for the pain independent of the bone lesion.
The candidate must start with the differential: Enchondroma vs. Atypical Cartilaginous Tumor (ACT)/Chondrosarcoma. They must highlight the clinical red flag: "Pain in an adult with a cartilaginous lesion is malignant until proven otherwise." The workup must be systematic: 1) Clinical history (night pain, growth); 2) Advanced imaging (MRI with contrast to evaluate enhancement patterns, CT to quantify endosteal scalloping >2/3 cortical thickness); 3) Rule out "mimics" (rotator cuff tendinopathy/OA); 4) Biopsy planning (if surgery is planned, the biopsy tract must be excisable).
MRI confirms a lesion with high T2 signal and significant endosteal scalloping. You decide to proceed with surgery. Describe your surgical planning, specifically how you would manage the potential for cortical weakness and the importance of adjuvants.
Candidate: I would use a deltopectoral approach. I’d create a cortical window and perform thorough intralesional curettage. I would use a burr to go into normal bone. I'd use an adjuvant like phenol or cryotherapy to kill remaining cells, then reconstruct with PMMA cement for immediate stability.
Neglecting the neurovascular risks during the approach (axillary nerve, circumflex vessels) or failing to explain *why* PMMA is used (thermal effect + structural support + ease of surveillance for recurrence). They often forget the "rectangular window with rounded corners" principle to mitigate stress risers.
A sophisticated answer details the technical steps: 1) Approach (Deltopectoral); 2) Precise cortical windowing (rounded corners to minimize stress concentration); 3) Meticulous intralesional curettage followed by high-speed burring (1-2mm into healthy bone); 4) Adjuvant therapy (Phenol/alcohol, H2O2, or cryotherapy) to reduce recurrence; 5) Reconstruction: PMMA cement is the gold standard for immediate stability and its dual role as a thermal adjuvant, while providing radiodensity that aids in postoperative surveillance for recurrence compared to bone graft.
During the procedure, your frozen section returns as a Grade II Chondrosarcoma. How does your surgical strategy change intraoperatively?
Candidate: I would stop the curettage immediately to avoid seeding. The diagnosis of Grade II Chondrosarcoma mandates a wide en bloc resection with negative margins rather than intralesional surgery.
Attempting to "convert" to a wider curettage or failing to recognize that Grade II+ tumors carry significant metastatic risk and require systemic workup and oncological resection.
1) Immediately abandon the intralesional plan to prevent further contamination. 2) Close the site meticulously. 3) Shift to a wide en bloc resection with clear margins, which is the oncologic requirement for high-grade tumors. 4) Discuss the necessity of proximal humeral endoprosthetic reconstruction, noting that soft tissue attachment (cuff repair) to the implant is critical for function, or opting for a reverse-geometry endoprosthesis if the rotator cuff is compromised.
